Pelizaeus-merzbacher Disease; Pmd
Description
Pelizaeus-Merzbacher disease is an X-linked recessive hypomyelinative leukodystrophy (HLD1) in which myelin is not formed properly in the central nervous system. PMD is characterized clinically by nystagmus, spastic quadriplegia, ataxia, and developmental delay (Inoue, 2005).
Clinical Features
Top most frequent phenotypes and symptoms related to Pelizaeus-merzbacher Disease; Pmd
- Intellectual disability
- Seizures
- Global developmental delay
- Short stature
- Generalized hypotonia
- Hearing impairment
- Microcephaly
- Scoliosis
- Ataxia
- Nystagmus
And another 70 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available PELIZAEUS-MERZBACHER DISEASE; PMD have a estimated prevalence of 0.25 per 100k worldwide.— The onset for some of the known clinical features related to this disease may vary, including infantile onset .
Alternative names
Pelizaeus-merzbacher Disease; Pmd Is also known as leukodystrophy, hypomyelinating, 1, hld1.
Researches and researchers
Doctors, researchs, and experts related to Pelizaeus-merzbacher Disease; Pmd extracted from public data.
Pelizaeus-merzbacher Disease; Pmd Experts map
Current Researchs and researchers
-
GÖTTINGEN — Pr Jutta GÄRTNER
Coordinator of expert centre - Clinical expert - Investigator of research project - Director of department
-
Institution/s:
— Universitätsmedizin Göttingen
— Universitätsmedizin Göttingen
— Zentrum Kinderheilkunde und Jugendmedizin - Abteilung Pädiatrie II, Universitätsmedizin Göttingen -
Research area/topic::
Clinical, molecular and functional characterization of connexin associated brain's white matter diseases (using the example of Pelizaeus-Merzbacher disease)
-
Institution/s:
-
GÖTTINGEN — Dr Marco HENNEKE
Clinical expert - Investigator of research project
-
Institution/s:
— Universitätsmedizin Göttingen
— Universitätsmedizin Göttingen -
Research area/topic::
Clinical, molecular and functional characterization of connexin associated brain's white matter diseases (using the example of Pelizaeus-Merzbacher disease)
-
Institution/s:
Pelizaeus-merzbacher Disease; Pmd Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
PLP1 Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
PLP1 Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
PLP1 Deletion/Duplication Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
PLP1 Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
PLP1 Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
PLP1 Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
PLP1
Specificity
100 %
Genes
100 % |
HSP, X-Linked Evaluation.
By Athena Diagnostics Inc (United States).
L1CAM, PLP1
Specificity
50 %
Genes
100 % |
HSP, Comprehensive Evaluation.
By Athena Diagnostics Inc (United States).
RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A , (...)
View the complete list with 4 more genes
Specificity
5 %
Genes
100 % |
You can get up to 116 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2 HAIM-MUNK SYNDROME; HMS ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C